T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$2.03B |
| 2 |
DuPont de Nemours
DD
|
+$1.83B |
| 3 |
Crown Castle
CCI
|
+$1.58B |
| 4 |
Microsoft
MSFT
|
+$1.48B |
| 5 |
TransUnion
TRU
|
+$781M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$1.72B |
| 2 |
Starbucks
SBUX
|
+$1.59B |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$1.3B |
| 4 |
Lowe's Companies
LOW
|
+$1.13B |
| 5 |
Philip Morris
PM
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Financials | 16.53% |
| 3 | Technology | 15% |
| 4 | Consumer Discretionary | 13.37% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
PACCAR
PCAR
$69.8B
| $196M | 0.03% |
4,066,836
-119,390
| -3% | -$5.39M |
|
452
East-West Bancorp
EWBC
$18.2B
| $196M | 0.03% |
3,278,191
-904,841
| -22% | -$51.4M |
|
453
PPG Industries
PPG
$25.8B
| $194M | 0.03% |
1,783,029
+90,999
| +5% | +$9.69M |
|
|
SGEN
454
DELISTED
Seagen Inc. Common Stock
SGEN
| $193M | 0.03% |
3,542,628
-302,890
| -8% | -$15.5M |
|
|
BPMC
455
DELISTED
Blueprint Medicines
BPMC
| $191M | 0.03% |
2,747,158
+273,173
| +11% | +$14.6M |
|
456
General Motors
GM
$78.4B
| $190M | 0.03% |
4,715,414
-134,916
| -3% | -$4.93M |
|
|
JOYY
457
JOYY Inc
JOYY
$3.7B
| $190M | 0.03% |
2,185,115
+129,501
| +6% | +$9.41M |
|
458
Towne Bank
TOWN
$3.46B
| $190M | 0.03% |
5,659,740
+13,938
| +0.2% | +$434K |
|
459
Zimmer Biomet
ZBH
$18.5B
| $190M | 0.03% |
1,667,113
+190,667
| +13% | +$22M |
|
460
Ford
F
$55.7B
| $189M | 0.03% |
15,776,841
-2,455,714
| -13% | -$27.7M |
|
461
Cal-Maine
CALM
$3.87B
| $188M | 0.03% |
4,583,928
+680,808
| +17% | +$25.4M |
|
462
Coty
COTY
$2.48B
| $188M | 0.03% |
11,365,401
-7,953,499
| -41% | -$144M |
|
|
CCI.PRA
463
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
| $188M | 0.03% |
+178,482
| New | +$193M |
|
464
Radian Group
RDN
$4.86B
| $187M | 0.03% |
10,030,568
+45,427
| +0.5% | +$788K |
|
465
Novanta
NOVT
$6.34B
| $187M | 0.03% |
4,294,666
+317,279
| +8% | +$12.3M |
|
466
BioMarin Pharmaceuticals
BMRN
$13.5B
| $187M | 0.03% |
2,009,051
+368,486
| +22% | +$32.6M |
|
467
Micron Technology
MU
$981B
| $185M | 0.03% |
4,693,278
+269,999
| +6% | +$8.54M |
|
468
Automatic Data Processing
ADP
$108B
| $184M | 0.03% |
1,685,702
-82,504
| -5% | -$8.84M |
|
469
Pool Corp
POOL
$7.32B
| $184M | 0.03% |
1,702,314
+163,215
| +11% | +$17.7M |
|
470
LivaNova
LIVN
$4.33B
| $183M | 0.03% |
2,618,951
+105,772
| +4% | +$6.7M |
|
471
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.9B
| $183M | 0.03% |
1,595,602
+729,600
| +84% | +$81.7M |
|
472
Brown & Brown
BRO
$23.9B
| $183M | 0.03% |
7,604,376
+552,286
| +8% | +$12.4M |
|
473
Sunstone Hotel Investors
SHO
$1.98B
| $183M | 0.03% |
11,372,667
+425,616
| +4% | +$6.76M |
|
474
CSX Corp
CSX
$92.5B
| $183M | 0.03% |
10,100,307
-3,563,565
| -26% | -$61.2M |
|
475
Gentherm
THRM
$1.27B
| $181M | 0.03% |
4,866,716
-22,398
| -0.5% | -$767K |
|
Similar funds
T. Rowe Price Associates's Q3 2017 Portfolio in Review
As of Q3 2017, T. Rowe Price Associates held 2,642 positions worth $585B, up 5.3% from $556B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
T. Rowe Price Associates's Q3 2017 filing shows 88 new, 1,025 increased, 900 reduced and 73 closed positions. Its largest new stake was Brighthouse Financial: 4,532,679 shares worth $276M. The largest sale was Du Pont De Nemours E I, an estimated $1.72B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q3 2017 buy was Brighthouse Financial: 4,532,679 shares worth $276M.
- T. Rowe Price Associates added most to Gen Digital in Q3 2017, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q3 2017 reduction was Starbucks, cutting an estimated $1.59B.
- T. Rowe Price Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.72B.
- T. Rowe Price Associates's ten largest holdings make up 18% of its $585B portfolio in Q3 2017.
- T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $585B.
Based on T. Rowe Price Associates's 13F filing for Q3 2017, filed 14 Nov 2017.